Trials / Unknown
UnknownNCT02022722
Trigger Point Injections and Pelvic Rehabilitation for the Treatment of Pelvic Floor Myalgia and Sexual Pain
Assessment Of Pain Subsidence And Sexual Function Amelioration Using Either Pelvic Rehabilitation Or Trigger Point Injections
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate which treatment option for pelvic floor pain allows for improved sexual function.
Detailed description
Pelvic floor pain may be treated with trigger point injections with medications (steroids and local anesthetics) that are FDA approved for injection into muscles. The alternative is a noninvasive treatment option using pelvic rehabilitation which involves vaginal muscle massage. Both treatment options have been used and reported; however, rapidity of improvement and return to normal sexual function have not been assessed. This study assigns patients to either treatment option randomly and the sexual function is assessed based on standardized sexual function questionnaires as well as pain ratings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trigger Point Injections Triamcinolone Acetonide, Bupivacaine Hydrochloride | The mixture is injected into the levator muscles, with half the volume on each side of the pelvic musculature. |
| PROCEDURE | Pelvic Rehabilitation | Pelvic floor massage will be performed on a weekly basis by a licensed physiotherapist specialized in pelvic floor pelvic therapy |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-04-01
- Completion
- 2014-06-01
- First posted
- 2013-12-30
- Last updated
- 2013-12-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02022722. Inclusion in this directory is not an endorsement.